semaglutide/tirzepatide weight loss treatment Tirzepatide vs. Semaglutide: Which Medication Is Right for You? Maintenance therapy on semaglutide or

As with all prescription medications, Wegovy should only be used under medical supervision as part of a comprehensive weight management programme that includes dietary changes and increased physical activity

Wegovy 7.2 mg achieved 20.7% average weight loss in the STEP UP trial, while Mounjaro 15 mg achieved 20.2% in the SURMOUNT-5 trial

The full FDA prescribing picture, up front

The average Fridays patient loses 9 lbs in the first month The average Fridays patient loses 9 lbs in the first month Everything you need, all in one place

Understanding Tirzepatide and Its Benefits in California Tirzepatide works by activating two hormone receptorsGLP-1 and GIPwhich regulate appetite, blood sugar, and metabolic rate

As of May, 2023, Tirzepatide is not FDA approved as a weight loss drug